Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial–Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes
International Journal of Molecular Sciences · 02.08.2026 · 27 (15) · 6951
DOI: 10.3390/ijms27156951 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2026. Verfasst von Zhonglu Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Integrins. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Bureau of Guangdong Province, Health Commission of Guangdong Province, Guangzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year survival rate below 10%. Cancer-associated fibroblasts (CAFs) promote epithelial–mesenchymal transition (EMT) and metastasis, yet the specific CAF subtypes and molecular axes driving PDAC progression remain incompletely understood. Here, using multi-omics data from PDAC samples, we identified a malignant ductal subpopulation, termed Ductal-T0, characterized by the highest EMT activity and prominent acquisition of myofibroblastic CAF (myCAF)-like transcriptional programs. Computationally, we predicted that myCAF-secreted THBS2 and FN1 engage the ITGA3/ITGB1/SDC1/SDC4 receptor axes in Ductal-T0 cells, which could activate TNF, NF-κB, TGF-β, and PI3K-AKT-signaling pathways to promote EMT. Pseudotime trajectory and velocity analyses suggested that Ductal-T0 cells exhibited the highest propensity to acquire myCAF-like features among all ductal subpopulations. Survival analysis revealed that an increased proportion of Ductal-T0 cells and elevated abundance of THBS2-ITGA3/ITGB1 and THBS2-SDC1 ligand–receptor pairs were significantly associated with poor prognosis. Spatial transcriptomics further revealed that myCAFs and Ductal-T0 cells co-localized at the tumor margin, which may contribute to reduced immune cell presence via dense extracellular matrix (ECM) barrier formation—a computationally inferred model of EMT-associated immune exclusion and metastatic progression—and identify THBS2 as a promising candidate for future therapeutic investigation to disrupt CAF–tumor crosstalk in PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Guangdong Province Precise Medicine Big Data of Traditional Chinese Medicine Engineering Technology Research Center, Guangzhou 510006, China.
- School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan 528458, China.
ORCID-Profile: Zhonglu Ren
Förderung
- Traditional Chinese Medicine Bureau of Guangdong Province
- Health Commission of Guangdong Province
- Guangzhou Municipal Science and Technology Bureau
- Undergraduate Innovation and Training Program
Zitieren
APA
Ren, Z., Li, Z., Wang, J., Liu, Y., Chen, L., Su, Y., Zhao, L., & Liu, X. (2026). Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial–Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes. International Journal of Molecular Sciences, 27(15), 6951. https://doi.org/10.3390/ijms27156951
Vancouver
Ren Z, Li Z, Wang J, Liu Y, Chen L, Su Y, et al. Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial–Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes. International Journal of Molecular Sciences. 2026;27(15):6951. doi:10.3390/ijms27156951
BibTeX
@article{Ren2026,
author = {Ren, Zhonglu and Li, Zhuangchang and Wang, Jie and Liu, Yuchen and Chen, Lidan and Su, Yuxin and Zhao, Limin and Liu, Xi},
title = {Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial–Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6951},
doi = {10.3390/ijms27156951}
}
EUVIMED